This is in contrast with immune mechanisms involved in diabetes development in the conventional NOD mouse, in which the highest efficiency of diabetes transfer is observed when both CD4+ and CD8+ T-cells are co-injected into naive NOD recipients (3). The gene discussed is CD8A; the disease is diabetes mellitus.